Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $24.74 million as of May 30, 2025. Its market cap has decreased by -53.42% in one year.

Market Cap

24.74M

Enterprise Value

n/a

Revenue

257.55M

Ranking

n/a

PE Ratio

2.08

Stock Price

$1.80

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from 39.11M to 24.74M, a decrease of -36.73%. That is a compound annual growth rate of -3.97%.

Market Cap History

Date	Market Cap	% Change
May 29, 2025	24.74M	280.00%
Dec 31, 2024	6.51M	-90.41%
Dec 29, 2023	67.92M	-82.15%
Dec 30, 2022	380.45M	-42.14%
Dec 31, 2021	657.57M	8.37%
Dec 31, 2020	606.81M	-26.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.62B
Veradigm	721.76M
Nika Pharmaceuticals	667.04M
Tian'an Technology Group	614.49M
Elite Pharmaceuticals	574.52M
Glass House Brands	459.97M
CytoDyn	421.23M
Northwest Biotherapeutics	386.43M

Market Cap Rankings